Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 26 studies | 39% ± 16% | |
fibroblast | 19 studies | 31% ± 14% | |
astrocyte | 18 studies | 48% ± 21% | |
ciliated cell | 17 studies | 36% ± 16% | |
smooth muscle cell | 15 studies | 30% ± 12% | |
oligodendrocyte | 15 studies | 44% ± 16% | |
oligodendrocyte precursor cell | 14 studies | 39% ± 19% | |
pericyte | 14 studies | 31% ± 15% | |
glutamatergic neuron | 12 studies | 52% ± 25% | |
macrophage | 12 studies | 38% ± 16% | |
microglial cell | 12 studies | 40% ± 12% | |
GABAergic neuron | 10 studies | 53% ± 24% | |
epithelial cell | 10 studies | 41% ± 19% | |
endothelial cell of lymphatic vessel | 9 studies | 34% ± 15% | |
type I pneumocyte | 9 studies | 48% ± 17% | |
neuron | 9 studies | 40% ± 22% | |
adipocyte | 9 studies | 51% ± 14% | |
myeloid cell | 8 studies | 30% ± 8% | |
amacrine cell | 7 studies | 34% ± 10% | |
interneuron | 7 studies | 54% ± 26% | |
mast cell | 7 studies | 25% ± 8% | |
retinal ganglion cell | 6 studies | 34% ± 12% | |
myofibroblast cell | 6 studies | 30% ± 16% | |
retina horizontal cell | 6 studies | 37% ± 9% | |
retinal cone cell | 6 studies | 23% ± 6% | |
dendritic cell | 6 studies | 27% ± 2% | |
mesothelial cell | 6 studies | 37% ± 12% | |
type II pneumocyte | 6 studies | 39% ± 11% | |
capillary endothelial cell | 5 studies | 22% ± 8% | |
retinal bipolar neuron | 5 studies | 28% ± 7% | |
B cell | 5 studies | 23% ± 6% | |
cardiac muscle cell | 5 studies | 40% ± 10% | |
lymphocyte | 5 studies | 26% ± 9% | |
Mueller cell | 5 studies | 30% ± 8% | |
monocyte | 5 studies | 32% ± 9% | |
club cell | 5 studies | 38% ± 12% | |
T cell | 5 studies | 24% ± 9% | |
basal cell | 5 studies | 36% ± 20% | |
abnormal cell | 4 studies | 34% ± 21% | |
glial cell | 4 studies | 30% ± 4% | |
granule cell | 4 studies | 34% ± 8% | |
retinal pigment epithelial cell | 4 studies | 53% ± 23% | |
vein endothelial cell | 4 studies | 32% ± 17% | |
retinal rod cell | 4 studies | 29% ± 7% | |
endothelial cell of vascular tree | 4 studies | 34% ± 19% | |
connective tissue cell | 4 studies | 26% ± 8% | |
goblet cell | 4 studies | 33% ± 25% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 3% | |
classical monocyte | 3 studies | 20% ± 5% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
hematopoietic precursor cell | 3 studies | 25% ± 7% | |
non-classical monocyte | 3 studies | 21% ± 3% | |
GABAergic interneuron | 3 studies | 52% ± 1% | |
plasma cell | 3 studies | 27% ± 6% | |
endothelial cell of artery | 3 studies | 18% ± 1% | |
mononuclear phagocyte | 3 studies | 29% ± 7% | |
GABAergic amacrine cell | 3 studies | 42% ± 8% | |
OFF-bipolar cell | 3 studies | 28% ± 6% | |
ON-bipolar cell | 3 studies | 31% ± 5% | |
glycinergic amacrine cell | 3 studies | 30% ± 1% | |
rod bipolar cell | 3 studies | 32% ± 7% | |
hepatocyte | 3 studies | 60% ± 13% | |
neural progenitor cell | 3 studies | 37% ± 15% | |
ependymal cell | 3 studies | 70% ± 11% | |
alveolar macrophage | 3 studies | 40% ± 11% | |
respiratory goblet cell | 3 studies | 37% ± 14% | |
muscle cell | 3 studies | 43% ± 33% | |
transit amplifying cell | 3 studies | 42% ± 31% | |
mural cell | 3 studies | 39% ± 10% | |
mucus secreting cell | 3 studies | 31% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3863.90 | 21 / 21 | 100% | 8.46 | 504 / 504 |
intestine | 100% | 3780.04 | 966 / 966 | 100% | 9.43 | 527 / 527 |
prostate | 100% | 4550.70 | 245 / 245 | 100% | 12.92 | 502 / 502 |
brain | 100% | 3657.82 | 2639 / 2642 | 100% | 12.38 | 705 / 705 |
ovary | 100% | 5337.63 | 180 / 180 | 100% | 12.31 | 429 / 430 |
breast | 100% | 3536.32 | 459 / 459 | 100% | 10.55 | 1115 / 1118 |
thymus | 100% | 3782.37 | 653 / 653 | 100% | 8.66 | 603 / 605 |
lung | 100% | 4051.25 | 577 / 578 | 100% | 9.83 | 1152 / 1155 |
adrenal gland | 100% | 4293.90 | 258 / 258 | 100% | 9.94 | 229 / 230 |
uterus | 100% | 4799.45 | 170 / 170 | 100% | 7.84 | 457 / 459 |
esophagus | 100% | 3306.22 | 1445 / 1445 | 99% | 14.47 | 182 / 183 |
skin | 100% | 2925.24 | 1808 / 1809 | 99% | 9.08 | 469 / 472 |
stomach | 100% | 2587.18 | 359 / 359 | 99% | 11.29 | 284 / 286 |
kidney | 100% | 3275.24 | 89 / 89 | 99% | 8.56 | 894 / 901 |
pancreas | 100% | 1566.46 | 327 / 328 | 99% | 8.10 | 176 / 178 |
liver | 100% | 2210.45 | 226 / 226 | 97% | 5.66 | 395 / 406 |
adipose | 100% | 3683.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3910.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3018.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.29 | 1 / 1 |
muscle | 100% | 2418.46 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2660.02 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 6.54 | 77 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.21 | 27 / 29 |
peripheral blood | 80% | 1316.31 | 747 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002091 | Biological process | negative regulation of receptor internalization |
GO_0016070 | Biological process | RNA metabolic process |
GO_0050658 | Biological process | RNA transport |
GO_0033962 | Biological process | P-body assembly |
GO_0034063 | Biological process | stress granule assembly |
GO_0006417 | Biological process | regulation of translation |
GO_0005802 | Cellular component | trans-Golgi network |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ATXN2 |
Protein name | Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) ATXN2 protein Ataxin 2 |
Synonyms | TNRC13 ATX2 SCA2 |
Description | FUNCTION: Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane. . |
Accessions | H0YH87 S4R3J6 ENST00000551755.6 ENST00000644883.1 ENST00000642389.2 A0A2R8YGV1 ENST00000475132.1 ENST00000647305.1 ENST00000550104.5 [Q99700-1] ENST00000389153.10 F8VQP2 A0A5F9ZH85 A0A5F9ZHH4 ENST00000673436.1 A0A2R8Y5A6 Q99700 ENST00000671792.1 ENST00000550236.1 Q2M2R5 ENST00000608853.5 F8WB06 A0A2R8Y6W7 A0A2R8YCG6 ENST00000643669.2 ENST00000542287.6 ENST00000673273.1 ENST00000672613.1 F8WB05 F8W0B5 A0A2R8Y7P6 ENST00000673557.1 A0A5F9ZHX3 ENST00000643474.1 A0A5F9ZHG6 ENST00000389154.7 F8VRK6 ENST00000673283.1 F8VZC1 V9GY86 ENST00000550844.2 ENST00000492467.6 A0A2R8Y7E6 S4R3R6 ENST00000616825.4 [Q99700-5] A0A2R8YDM9 ENST00000673449.1 ENST00000643694.1 ENST00000535949.5 [Q99700-5] ENST00000647445.1 A0A5F9ZHW5 ENST00000483311.6 A0A5F9ZI57 |